Welcome Panthers Fans!

Check Out The All NEW & Original Carolina Panthers Den Message Board! - Many New Improvements & Features For Everyone! - New Photo Gallery Added!.... Please Register To Participate On The Forums Today! .... Updated 2007 Panthers Schedule Posted In Our Forums! .... Join Us For All The LATEST News & Discussions On Your Carolina Panthers Everyday!: Keyshawn Johnson Cut by Panthers!-Discuss on our Message Board NOW! .... Download Our NEW Panthers Den Toolbar And Get Panthers News Sent To Your Desktop! ..... Plenty Of Fun & Games: Enter Our Arcade Tournaments And Compete Against Other Forum Members! ....Try Our New Sports Bookie & Casino And Rack Up Your 'Gold Points!' .....Login To See Who Our Newest Member Of The Month Is And Find Out How YOU Can Be Our Next WINNER!!! .... We Have Something For Everyone! - Don't Miss Out On All The "Crazy Feline Fun!" At Carolina Panthers Den! - The Most "Interactive" Panthers Fansite & Message Board On The Net!!! - GUARANTEED!!!


NEWS RELEASE Tokyo.

NEWS RELEASE Tokyo, Japan, 23 July, 2015 – Astellas Pharma Inc. announced that it has initiated a collaborative analysis with the National Institute of Advanced Industrial Technology and Technology utilizing Astellas’ personal protein-ligand complex structural information1) and AIST’s highly advanced IT drug-discovery technologies sildalist.org/sildalis-online.html http://sildalist.org/sildalis-online.html . A candidate compound is a substance which includes the potential to become a drug that plays a role by acting on proteins that trigger diseases. Astellas has accumulated wealthy structural information of pharmaceutical focus on proteins complexed with applicant compounds, and the number of protein-ligand complex structures becomes 10 approximately,000.

sildalist use

Product sales in america were unchanged, because the $141 million decline in product sales of Toprol-XL from generic competition was offset by 5 % development in all of those other US business. Product sales in the others of World had been up 6 %. Sales in Established Marketplaces were 2 % up. The strong functionality in Emerging Marketplaces continues, with product sales up 18 % to $1,116 million, which accounted for just two thirds of the others of World sales boost. Core operating income in the 3rd quarter was up 15 % to $2,771 million, chiefly due to the sales increase, improvement in Primary gross margin and R&D efficiencies.